Two studies show positive results for ADHD treatment

04/7/2005 | Reuters

Positive results from two studies were reported for a once-a-day skin patch being developed by Noven Pharmaceuticals and Shire Pharmaceuticals for treatment of attention deficit hyperactivity disorder. The treatment was well tolerated and the objectives of both studies were achieved, Noven said, adding the data will be included in an amended drug application pending at the U.S. FDA. The patch is intended for children ages 6 to 12 who suffer from ADHD.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA